Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CRH | NUE |
|---|---|---|
| Price | $83.83 | $250.09 |
| Change today | ▼ 1.64% | ▲ 1.26% |
| Market cap | $55.77B | $56.74B |
| Return, 3 months | -24.9% | +4.2% |
| Return, year to date | -32.1% | +54.2% |
| Return, 1 year | -24.5% | +85.8% |
| P/E (TTM) | 14.8 | 20.0 |
| P/B | 2.3 | 2.6 |
| P/E percentile vs own 5y | 35th | 76th |
| Dividend yield | 1.81% | 0.89% |
| Revenue growth (YoY, latest qtr) | +5.6% | +23.0% |
| Net profit growth (YoY) | +13.4% | +81.3% |
| Gross margin | 36.2% | 15.5% |
| Operating margin | 14.1% | 11.5% |
| Net margin | 9.9% | 8.0% |
| Return on equity | 16.4% | 13.5% |
| Analyst target vs. price | +62.6% | +14.6% |
| Analyst buy share | 100% | 80% |
| RSI (14) | 34 | 44 |
| 30-day volatility | 27.1% | 36.9% |
| Max drawdown, 1 year | -34.1% | -18.4% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.